These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20977502)

  • 1. Infliximab administration effective in the treatment of refractory Kawasaki disease.
    Accomando S; Liotta A; Maggio MC; Cardella F; Corsello G
    Pediatr Allergy Immunol; 2010 Nov; 21(7):1091-2. PubMed ID: 20977502
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study.
    Son MB; Gauvreau K; Burns JC; Corinaldesi E; Tremoulet AH; Watson VE; Baker A; Fulton DR; Sundel RP; Newburger JW
    J Pediatr; 2011 Apr; 158(4):644-649.e1. PubMed ID: 21129756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advance in diagnosis and treatment of intravenous immunogolobulin-resistant Kawasaki disease].
    Zhang Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):318-21. PubMed ID: 19374823
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab treatment for refractory Kawasaki syndrome.
    Burns JC; Mason WH; Hauger SB; Janai H; Bastian JF; Wohrley JD; Balfour I; Shen CA; Michel ED; Shulman ST; Melish ME
    J Pediatr; 2005 May; 146(5):662-7. PubMed ID: 15870671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series.
    Mori M; Imagawa T; Hara R; Kikuchi M; Hara T; Nozawa T; Miyamae T; Yokota S
    J Rheumatol; 2012 Apr; 39(4):864-7. PubMed ID: 22337241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti TNF-α (infliximab) treatment for intravenous immunoglobulin (IVIG) resistance patients with acute Kawasaki disease the effects of anticytokine therapy].
    Saji T; Takatsuki S; Kobayashi T
    Nihon Rinsho; 2014 Sep; 72(9):1641-9. PubMed ID: 25518416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 5-year-old boy with fever and rash. Incomplete Kawasaki disease.
    Kallada S
    Pediatr Ann; 2011 Apr; 40(4):185-7. PubMed ID: 21485993
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab as a novel therapy for refractory Kawasaki disease.
    Weiss JE; Eberhard BA; Chowdhury D; Gottlieb BS
    J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of TNFalpha blockade in complicated, refractory Kawasaki disease.
    Stenbøg EV; Windelborg B; Hørlyck A; Herlin T
    Scand J Rheumatol; 2006; 35(4):318-21. PubMed ID: 16882598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin.
    Shirley DA; Stephens I
    Pediatr Infect Dis J; 2010 Oct; 29(10):978-9. PubMed ID: 20431427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should infliximab be used as an adjuvant to IVIG in the treatment of children with Kawasaki disease who are at high risk for resistance to conventional therapy?
    Davies S; Gold-von Simson G
    Pediatr Cardiol; 2013 Oct; 34(7):1756. PubMed ID: 23771701
    [No Abstract]   [Full Text] [Related]  

  • 12. An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes.
    Yim D; Curtis N; Cheung M; Burgner D
    J Paediatr Child Health; 2013 Aug; 49(8):614-23. PubMed ID: 23647873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistant Kawasaki disease.
    Nachiappan J; May M; Hawker RE; Hong P
    J Paediatr Child Health; 2004; 40(9-10):576-8. PubMed ID: 15367156
    [No Abstract]   [Full Text] [Related]  

  • 14. Mucocutaneous lymph node syndrome (Kawasaki disease): report of case with atypical features.
    Sciamanna DS; Santucci TF
    J Am Osteopath Assoc; 1979 Sep; 79(1):82-4. PubMed ID: 489435
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute renal failure and febrile rash--infectious or not? Adult Kawasaki disease (KD).
    El Karoui K; Servais A; Fadel F; Jablonski M; Fakhouri F; Lesavre P; Hummel A
    Nephrol Dial Transplant; 2007 Mar; 22(3):949-51. PubMed ID: 17210597
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab as the First Retreatment in Patients with Kawasaki Disease Resistant to Initial Intravenous Immunoglobulin.
    Youn Y; Kim J; Hong YM; Sohn S
    Pediatr Infect Dis J; 2016 Apr; 35(4):457-9. PubMed ID: 26673981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Refractory Kawasaki disease with coronary aneurysms treated with infliximab].
    Salguero JS; Durán DG; Peracaula CS; Iznardi CR; Tardío JO
    An Pediatr (Barc); 2010 Nov; 73(5):268-71. PubMed ID: 20678974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab treatment for pediatric refractory Kawasaki disease.
    Blaisdell LL; Hayman JA; Moran AM
    Pediatr Cardiol; 2011 Oct; 32(7):1023-7. PubMed ID: 21773835
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistant Kawasaki disease treated with anti-CD20.
    Sauvaget E; Bonello B; David M; Chabrol B; Dubus JC; Bosdure E
    J Pediatr; 2012 May; 160(5):875-6. PubMed ID: 22341587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The mucocutaneous lymph node syndrome (Kawasaki syndrome). A case with gallbladder hydrops and coronary artery aneurysm].
    Fritz ME; Giambonini S; Jenni R; D'Apuzzo V
    Schweiz Med Wochenschr; 1981 Apr; 111(16):566-71. PubMed ID: 7233135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.